Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Hong

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science Translational Medicine|November 26, 2025
An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade gliomaNader Sanai, Artak Tovmasyan, An-Chi Tien, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science Translational Medicine|November 26, 2025
An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade gliomaNader Sanai, Artak Tovmasyan, An-Chi Tien, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Pageof 2